Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|June 6, 2022
Linear DNA amplicons as a novel cancer vaccine strategyAntonella Conforti, Erika Salvatori, Lucia Lione, et al.
Behavioral Sciences (Basel, Switzerland)|March 24, 2022
Managing the Consequences of Oncological Major Surgery: A Short- and Medium-Term Skills Assessment Proposal for Patient and Caregiver through M.A.D.I.T. MethodologyGian Piero Turchi, Alessandro Fabbian, Rita Alfieri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 24, 2020
QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancerEleonora Pinto, Maria Teresa Nardi, Rita Marchi, et al.
Vaccines|July 27, 2022
DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret ModelMirco Compagnone, Eleonora Pinto, Erika Salvatori, et al.
Molecular Therapy. Methods & Clinical Development|January 9, 2023
A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic catsAntonella Conforti, Elisa Sanchez, Erika Salvatori, et al.
Archives of Virology|March 29, 2023
A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferretsMathias Martins, Gabriela M do Nascimento, Antonella Conforti, et al.
Journal for Immunotherapy of Cancer|May 13, 2026
Synthetic DNA vaccine platform elicits potent immunity where electroporated naked-mRNA is non-immunogenicClaudia Tonini, Andrea Bianchi, Mauro Esposito, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2026
Comorbidity, treatment toxicity and satisfaction with cancer care: an international cross-sectional study based on the EORTC PATSAT-C33 and OUT-PATSAT7Anne Brédart, Jean-Luc Kop, Omar Shamieh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2022
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19Luigi Aurisicchio, Nadia Brambilla, Marina E Cazzaniga, et al.
Pageof 4